<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>26810907</identifier>
<setSpec>1989-7286</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Marticorena-Álvarez, P</dc:author>
<dc:author>González Guijarro, J</dc:author>
<dc:description xml:lang="en">CASE REPORT After inadvertent intravitreal injection of Celestone® (betamethasone sodium phosphate and acetate, benzalkonium chloride) in a patient, the macular spectral domain optical coherence tomography (SD-OCT) images showed hyper-reflectivity, thinning, and irregular spikes in the inner retinal layers. These early findings could explain the toxic secondary anatomical changes due to the drug itself and/or to its excipients. Late and permanent SD-OCT findings included changes in the ellipsoid zone and cystic-like spaces. DISCUSSION In this case, SD-OCT images can help to better understand the pathophysiology of the retinal damage and to diagnose the associated complications, providing information with prognostic value.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:subject>Retinal toxicity</dc:subject>
<dc:subject>Celestone®</dc:subject>
<dc:subject>Ellipsoid line</dc:subject>
<dc:subject>Toxicidad retiniana</dc:subject>
<dc:subject>OCT-SD</dc:subject>
<dc:subject>Intraocular injection</dc:subject>
<dc:subject>Línea de los elipsoides</dc:subject>
<dc:subject>Inyección intraocular</dc:subject>
<dc:date>2016 Mar </dc:date>
<dc:title xml:lang="en">Spectral domain optical coherence tomography in Celestone® retinal toxicity.</dc:title>
<dc:publisher>Archivos de la Sociedad Espanola de Oftalmologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
